Elevation Oncology Inc (NASDAQ: ELEV) Up Almost 5.33% In One Month, Long Term Looking Good
Elevation Oncology Inc (NASDAQ:ELEV)’s traded shares stood at 1.0 million during the last session, with the company’s beta value hitting 1.48. At the close of